Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Continuous Transcutaneous CO2 Monitoring (TCCO2) in Extremely Low Birth Weight (ELBW) Infants: A Prospective Observational, Multi-Center Study

NCT03477708 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT03477708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Continuous Transcutaneous CO2 Monitoring (TCCO2) in Extremely Low Birth Weight (ELBW) Infants: A Prospective Observational, Multi-Center Study
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
April 1, 2022
Enrollment
166 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elbw - extremely low birth weight infant, ivh- intraventricular hemorrhage